Results 181 to 190 of about 958,890 (240)

Investigation of the transcriptional impact of rare germline JAK/STAT variants found in a Tyrolean alpine community. [PDF]

BMC Genomics
Hennighausen L, Haikarainen T, Lee SG, Caf Y, Furth PA, Silvennoinen O, Lee HK, Knabl L.   +7 more
europepmc   +1 more source

REAL-WORLD EXPERIENCE WITH JANUS KINASE INHIBITORS IN EXTRAINTESTINAL MANIFESTATIONS AND INFLAMMATORY BOWEL DISEASE IN COLOMBIA: A COMPARATIVE STUDY (JAKEIM-IBD STUDY). [PDF]

Arq Gastroenterol
Parra-Izquierdo V, Ardila O, Márquez JR, Riveros J, Gómez-Venegas ÁA, Medrano-Almanza CA, Ballesteros M, Barreto-Pérez J, Frias-Ordoñez JS.   +8 more
europepmc   +1 more source

Być jak Modrzejewska!

Zarządzanie w Kulturze
Aleksandra Kuczara
doaj   +1 more source

JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase. [PDF]

Fundam Clin Pharmacol
Duboëlle M, Lercara A, Pers YM, Michel C, Lepelley M, Valnet-Rabier MB, Faillie JL, Bres V, Palassin P.   +8 more
europepmc   +1 more source

Jak zaakceptować symulakrum

Dziennikarstwo i Media
Dominik Lewiński
doaj   +1 more source

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile. [PDF]

J Intern Med
Pagis V, Astouati Q, Pacoureau L, Nguyen Y, Bay P, Roux A, Gallay L, Cottin V, Terrier B, Meyer A, Cerf C, Neuville M, Hervier B, Renaud A, Suzon B, Schleinitz N, Papo T, Priou P, Mekinian A, Ullmer A, Oehler E, Gensous N, Berezne A, Martin LS, Marhadour T, Martin M, Servettaz A, Samson M, Gilardin L, Charles P, Woessner J, Carmoi T, Dilly B, Mauhin W, Baillet N, Humbert S, Thoreau B, Lemaitre M, Pendu CL, Loiseau P, Quemeneur T, Blanchard E, Voermans N, Launay D, Nunes H, Benveniste O, Uzunhan Y, Allenbach Y.   +47 more
europepmc   +1 more source

JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. [PDF]

J Ophthalmic Inflamm Infect
Almerri S, Alshatti H, Ali YT, Behbehani R.   +3 more
europepmc   +1 more source

Impact of Long-Term Glucocorticoid Therapy on the Response to Biologic Agents in Rheumatoid Arthritis: A Prospective Observational Study. [PDF]

Cureus
Sagara M, Majjad A, Toufik H, Ahmed B.
europepmc   +1 more source

Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]

Pediatr Rheumatol Online J
Lamers HC, Van Nieuwenhove E, Vastert SJ, Jansen MHA, van Royen-Kerkhof A, Swart JF, de Roock S.   +6 more
europepmc   +1 more source

Differential response to Janus kinase inhibitors in refractory livedoid vasculopathy: Biomarker-guided therapy may improve clinical response. [PDF]

JAAD Int
Yu G, Zhu J, Zhang Y, Yang F, Yang J, Tao J.   +5 more
europepmc   +1 more source